Financial statements Pharmag

Balance sheet of Pharmag

Company age:
Age:
24 y. 27 d.
Share capital:
Share capital:
5 891 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of PHARMAG

Year
2018
2019
2020
2021
2022
2023
Total assets 9 547 308,70 8 300 434,31 7 849 811,08 7 297 214,19 6 448 694,65 6 049 048,11
A. Fixed assets 8 641 213,52 7 523 988,26 6 901 156,96 6 203 162,24 5 824 759,34 5 363 374,24
B. Current assets 906 095,18 776 446,05 948 654,12 1 094 051,95 623 935,31 685 673,87
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 9 547 308,70 8 300 434,31 7 849 811,08 7 297 214,19 6 448 694,65 6 049 048,11
A. Equity -2 695 001,58 -3 522 746,73 -3 570 101,99 -3 714 294,71 -4 181 463,65 -4 854 763,39
B. Liabilities and provisions for liabilities 12 242 310,28 11 823 181,04 11 419 913,07 11 011 508,90 10 630 158,30 10 903 811,50
I. Long-term liabilities 10 706 378,15 10 289 305,36 9 776 313,72 9 357 065,08 9 027 749,19 9 286 946,47
II. Short-term liabilities 1 527 432,13 1 524 875,68 1 625 099,35 1 635 443,82 1 573 409,11 1 577 865,03
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.